Correction to: British Journal of Cancer (2016) 115, 1548–1554. doi:https://doi.org/10.1038/bjc.2016.367; published online 10 November 2016

Since publication of this manuscript, it was recognised that there is an error in Figure 3D and E of the results. The correct figure is presented here.

Figure 3
figure 1

Notch2 promotes EMT of ESCC. (A) shRNA transfection of Notch2 could inhibit its expression. (B, C) shRNA-Notch2 inhibited invasion ability of ESCC. (D, E) shRNA-Notch2 regulated EMT markers of ESCC. **P<0.01; ***P<0.001.

The sample labels for ‘anti-Notch 2’ and ‘NC’ were incorrectly placed for the EC 9706 and Eca 109 cell lines in Figure 3D and E, and the protein ‘vimentin’ was incorrectly labelled as ‘N-Cadherin’ in Figure 3D. The results are correctly described in the main text of the manuscript, and the incorrect figure had no effect on the overall study conclusions.